VBI Vaccines Inc expected to post a loss of 53 cents a share - Earnings Preview

VBI Vaccines

10/05/2024 15:32

* VBI Vaccines Inc  VBIV.OQ   VBIV.O  is expected to show a
rise
in quarterly revenue when it reports  results on May 13
(estimated) for the period ending March 31 2024
    * The Cambridge Massachusetts-based  company is expected to
report
a 488.0% increase in revenue to $2.852 million from $485
thousand a year ago, according to the estimate from one analyst,
based on LSEG data.
    * ​LSEG's mean analyst estimate for VBI Vaccines Inc is for
a loss
of 53 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for VBI
Vaccines Inc
is $5.00​, above​ its last closing price of $0.60. ​​​

This summary was machine generated May 10 at 14:32 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)